Avadel Pharmaceuticals plc - ADR

NASDAQ:AVDL   3:59:44 PM EDT
7.34
+0.17 (+2.37%)
Earnings Announcements

Avadel Pharmaceuticals Reports Third Quarter 2020 Financial Results

Published: 11/09/2020 12:23 GMT
Avadel Pharmaceuticals PLC (AVDL) - Avadel Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Update on Ft218 Development Program.
Q3 Loss per Share $0.20.
Q3 Earnings per Share Estimate $-0.18 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.26

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.26

More details on our Analysts Page.